Insiders bought 451K and sold $1.44M on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director Christopher A Kuebler sold $1.44M on Aug 6, 17% of their stake, outside a plan.
Get an email when WAT's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 6 | Christopher A Kuebler Director | SoldNo plan | 3,626 | $397.94 | $1.44M | 17% | Form 4 |
| Mar 16 | Wei Jiang Director | Bought | 500 | $289.46 | 145K | 17% | Form 4 |
| Mar 6 | Richard H Fearon Director | Bought | 1,000 | $306.34 | 306K | 43% | Form 4 |
- Aug 6No planChristopher A KueblerDirector · sold 3,626 at $397.94$1.44M17% of stake
- Mar 16Wei JiangDirector · bought 500 at $289.46145K17% of stake
- Mar 6Richard H FearonDirector · bought 1,000 at $306.34306K43% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Laboratory Analytical Instruments · Pick stocks to compare with WAT
Held by ETFs
WAT is in 255 US ETFs. The largest of them, with WAT's weight in each:
Spot a number that looks wrong? Check it in WAT's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing WAT
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.